SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Snap, Inc. is a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap Inc is trending as the community reacts to the unveiling of its new $2,195 AR smart glasses, with investors debating whether the hardware is a visionary step forward or a costly mistake. While bulls emphasize the potential of the AR ecosystem and Snap's massive user base, bears remain skeptical of the high price point, poor stock performance, and the leadership's focus on hardware over advertising revenue.

Groupon, Inc. engages in the global scaled two-sided marketplace that connects consumers to merchants. It operates through the North America and International geographical segments. The company was founded by Andrew D. Mason, Eric Paul Lefkofsky, and Bradley A. Keywell in October 2008 and is headquartered in Chicago, IL.

Groupon Inc

Groupon is experiencing a surge in bullish sentiment driven by a potential short squeeze setup, characterized by high short interest and a shrinking float fueled by active share buybacks. Community members are actively sharing technical analysis and options flow data to encourage holding, while monitoring potential catalyst events like AI integration and upcoming quarterly updates.

Western Digital Corp. engages in the development, manufacture, marketing, and sale of data storage devices and solutions. The company was founded by Alvin B. Phillips in 1970 and is headquartered in San Jose, CA.

Western Digital Corp.

Western Digital is experiencing significant volatility as investors debate whether the company's role in the AI data infrastructure cycle warrants current valuations or indicates a speculative bubble. While the stock has benefited from institutional accumulation and positive analyst price target revisions tied to storage demand, community discourse remains sharply divided between those positioning for further gains and skeptics calling for a correction amid signs of overextension.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble Inc. is trending as investors anticipate the finalization of the Northern Data acquisition, which is expected to bolster the company's AI infrastructure with 22,000 Nvidia GPUs and significantly increase forward revenue. The community is actively discussing the potential for a major short squeeze and a significant revaluation of the stock, driven by strong backing from Tether and ongoing speculation about potential government cloud contracts.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is facing heightened volatility and intense community debate as investors react to debunked acquisition rumors, sparking frustration over stagnant price action despite the company's strong cash position and ongoing share buyback program. Traders are actively weighing the stock's long-term potential as a streaming leader against technical exhaustion, with many discussing whether recent dips present a value opportunity or a sign of deeper underlying weakness.

Magnite, Inc. provides a technology solution to automate the purchase and sale of digital advertising inventory for buyers and sellers. It features applications and services for digital advertising sellers including websites, mobile applications, and other digital media properties. The company was founded by Frank Addante, Duc Chau, Craig Roah, Julie Mattern and Brian D. Baumgart on April 20, 2007 and is headquartered in New York, NY.

Magnite Inc

Magnite is currently trending as investors weigh solid CTV growth and an aggressive share buyback plan against broader ad-tech sector volatility. The community remains focused on the potential impact of the upcoming Google antitrust remedies and the long-term role of Magnite's infrastructure within an increasingly AI-driven advertising economy.

Lionsgate Studios Corp. operates as a standalone, pure-play content company focused on creating, producing, and distributing premium entertainment across multiple formats and platforms. It operates through the following segments: Motion Picture and Television Production. The Motion Picture segment includes the development and production of feature films, acquisition of North American and worldwide distribution rights, North American theatrical, home entertainment, and television distribution of produced and acquired films, as well as the worldwide licensing of distribution rights. The Television Production segment covers the development, production, and worldwide distribution of television content, including series, television movies, mini-series, and non-fiction programming. The company was founded on January 13, 2024 and is headquartered in Vancouver, Canada.

Lionsgate Studios Corp. - Ordinary Shares - New

Lionsgate Studios Corp.

Lionsgate Studios is trending as investors react to a report refuting rumors of a Netflix takeover, sparking community debate over the studio's M&A prospects and its value as a standalone entity. The stock has seen heightened volatility and active discussion regarding its intellectual property potential, with sentiment split between those anticipating a bidding war and others concerned about the studio's operational performance.

Investment Managers Series Trust II - Tradr 2X Short SpaceX Daily ETF

Tradr 2X Short SpaceX Daily ETF

Tradr's 2X Short SpaceX Daily ETF is capturing significant attention as traders weigh in on the volatility and valuation of the recently public space exploration company. The community is actively debating the use of this leveraged product as a hedge or speculative tool, with many closely watching for potential pullbacks in the underlying stock to justify their short positions.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

FuboTV is seeing increased retail engagement driven by the return of NBCUniversal content and anticipation for the 2026 FIFA World Cup. While bullish participants point to Disney's strategic backing and a potential short squeeze, many in the community remain skeptical due to historically poor management, dilution concerns, and a long-term downward trend.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is trending as investors weigh the potential for a regulatory path following positive phase 3 data against ongoing community debates regarding the necessity of additional trials for FDA approval. Discussion is centered on the upcoming investor day, persistent short interest, and the evolving prospects of a strategic partnership or buyout.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Given Consensus Recommendation of "Moderate Buy" by Analysts

Unicycive Therapeutics, Inc. (NASDAQ:UNCY - Get Free Report) has been assigned an average recommendation of "Moderate Buy" from the six analysts that are presently covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation and five...

Unicycive Therapeutics (NASDAQ:UNCY) Downgraded to Sell Rating by Wall Street Zen

Wall Street Zen cut shares of Unicycive Therapeutics from a "hold" rating to a "sell" rating in a research note on Saturday...

B. Riley Financial Begins Coverage on Unicycive Therapeutics (NASDAQ:UNCY)

B. Riley Financial assumed coverage on shares of Unicycive Therapeutics in a report on Friday. They issued a "buy" rating and a $22.00 price target on the stock...

Equities Analysts Offer Predictions for UNCY Q1 Earnings

Unicycive Therapeutics, Inc. (NASDAQ:UNCY - Free Report) - Analysts at Brookline Capital Markets issued their Q1 2026 earnings per share estimates for Unicycive Therapeutics in a research note issued on Tuesday, April 7th. Brookline Capital Markets analyst K. Raja expects that the company will post...

Unicycive Therapeutics, Inc. (NASDAQ:UNCY) Given Consensus Rating of "Moderate Buy" by Brokerages

Unicycive Therapeutics, Inc. (NASDAQ:UNCY - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the five ratings firms that are currently covering the firm, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation and four have assi...

Kuehn Law Encourages Investors of Unicycive Therapeutics, Inc. to Contact Law Firm

Kuehn Law Encourages Investors of Unicycive Therapeutics, Inc. to Contact Law Firm Kuehn Law Encourages Investors of Unicycive Therapeutics, Inc. to Contact Law Firm PR Newswire NEW YORK, April 9, 2026 NEW YORK, April 9, 2026 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is...

Brookline Capital Markets Estimates UNCY Q2 Earnings

Unicycive Therapeutics, Inc. (NASDAQ:UNCY - Free Report) - Brookline Capital Markets issued their Q2 2026 earnings per share estimates for shares of Unicycive Therapeutics in a report issued on...

Benchmark Cuts Unicycive Therapeutics (NASDAQ:UNCY) Price Target to $15.00

Benchmark lowered their target price on shares of Unicycive Therapeutics from $21.00 to $15.00 and set a "speculative buy" rating for the company in a research note on Monday...

HC Wainwright Issues Positive Estimate for UNCY Earnings

Unicycive Therapeutics, Inc. (NASDAQ:UNCY - Free Report) - Equities research analysts at HC Wainwright increased their Q1 2026 EPS estimates for Unicycive Therapeutics in a note issued to investors on Tuesday, March 31st. HC Wainwright analyst S. Ramakanth now anticipates that the company will post...

Guggenheim Has Lowered Expectations for Unicycive Therapeutics (NASDAQ:UNCY) Stock Price

Guggenheim decreased their price target on Unicycive Therapeutics from $46.00 to $40.00 and set a "buy" rating on the stock in a research note on Thursday...

Unicycive Therapeutics, Inc. is a biotechnology company, which engages in developing novel treatments for kidney diseases. The firm investigational treatment is oxylanthanum carbonate, a novel phosphate binding agent currently under review by the U.S. Food and Drug Administration (FDA) for the treatment of hyperphosphatemia in patients with chronic kidney disease who are on dialysis. Unicycive’s second investigational treatment UNI-494 is intended for the treatment of conditions related to acute kidney injury. It has been granted orphan drug designation (ODD) by the FDA for the prevention of Delayed Graft Function (DGF) in kidney transplant patients and has completed a Phase 1 dose-ranging safety study in healthy volunteers. The company was founded by Shalabh Gupta on August 18, 2016 and is headquartered in Los Altos, CA.

UNCYUnicycive Therapeutics Inc

Fundamentals

Feed

News

Sentiment

Fundamentals

Info

Latest UNCY News